TORONTO, March 13, 2025 /PRNewswire/ -- Public Sector Pension Investment Board (PSP Investments), one of Canada's largest pension investors, today announced that it has entered into agreements to ...

Table 01: Global Glass Vials Market Historic Value (US$ Bn), By Glass Type 2015(H)-2021(A) Table 02: Global Glass Vials Market Forecast Value (US$ Bn), By Glass Type 2022(E)-2032(F) Table 03: Global ...

Biogen and Ionis Pharmaceuticals’ Spinraza could be on the US market within weeks after a phase 3 trial in the rare neuromuscular disorder, spinal muscular atrophy, met its goal. The ...

Spinal muscular atrophy (SMA) therapy Spinraza has been a key earner for Biogen in recent years, but with sales now heading into reverse, the company is looking to extend its franchise.

TORONTO, March 5, 2025 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN/DHT.U) ("DRI" or "the Trust") today informs its unitholders of an adjustment to its previously announced quarterly cash ...

Shane here! I just wanted to quick put up some reflections on my day today. I got my 7th Spinraza injection and it was quite a long day! Manfred considering petition to have Rose posthumously ...

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

PARADIS, La. (WVUE) - Three employees of R.J. Vial Elementary School in St. Charles Parish have been arrested following an investigation into alleged mistreatment of a student, authorities ...

Eli Lilly announced Tuesday that it is selling higher-dose vials of Zepbound at lower prices in its direct-to-consumer program. The program offers self-administered vials for people whose insurance ...

Spinraza (nusinersen) treatment may help restore balance to the levels of some lipids, fat-like molecules that are lower in the cerebrospinal fluid (CSF) of children with spinal muscular atrophy (SMA) ...

Eli Lilly (NYSE:LLY) announced Tuesday it expanded its weight loss drug offerings, launching new 7.5 mg and 10 mg single-dose vial formats of its popular weight loss therapy Zepbound (tirzepatide ...